XML 37 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Cash, cash equivalents, and available-for-sale marketable securities
9 Months Ended
Sep. 30, 2019
Cash, cash equivalents, and available for sale marketable securities  
Cash, cash equivalents, and available for sale marketable securities

4. Cash, cash equivalents, and available-for-sale marketable securities

Cash equivalents include all highly liquid investments maturing within 90 days from the date of purchase. Marketable securities consist of securities with original maturities greater than 90 days when purchased. The Company

classifies these investments as available-for-sale and records them at fair value in the accompanying condensed consolidated balance sheets.

The Company classifies marketable debt securities with a remaining maturity when purchased of greater than three months as available-for-sale. Marketable debt securities with a remaining maturity date greater than one year and marketable equity securities are classified as non-current where the Company has the intent and ability to hold these securities for at least the next 12 months. Available-for-sale debt securities are maintained by an investment manager and consist of U.S. Treasury notes. In 2016, the Company invested in a supplier and received common stock and warrants to purchase common stock in that entity. The common stock is included in non-current marketable securities and the warrants are included in non-current assets.

All available-for-sale securities are carried at fair value with the unrealized gains and losses included in other comprehensive loss as a component of stockholders’ equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the underlying investment. Realized gains and losses are determined using the specific identification method and are included in other income (expense). If any adjustment to fair value reflects a decline in value of the investment, the Company considers all available evidence to evaluate the extent to which the decline is “other-than-temporary” and, if so, recognizes the unrealized loss through a charge to the Company’s condensed consolidated statement of operations and comprehensive loss. No other-than-temporary losses have been recognized.

Money market funds and marketable securities included the following at September 30, 2019 and December 31, 2018:

Amortized

Unrealized

Unrealized

Fair

    

Cost

    

Gains

    

Losses

    

Value

(in thousands)

As of September 30, 2019

    

    

    

    

    

    

    

    

Money market funds included in cash and cash equivalents

$

81,711

$

$

$

81,711

Marketable securities:

U.S. Treasury notes

 

224,647

 

113

 

 

224,760

Equity securities

1,220

804

2,024

Total marketable securities

$

225,867

$

917

$

$

226,784

Total money market funds and marketable securities

$

307,578

$

917

$

$

308,495

As of December 31, 2018

    

    

    

    

    

    

    

    

Money market funds included in cash and cash equivalents

$

46,173

$

$

$

46,173

Marketable securities:

U.S. Treasury notes

 

108,951

1

5

 

108,947

Equity securities

1,220

592

628

Total marketable securities

$

110,171

$

1

$

597

$

109,575

Total money market funds and marketable securities

$

156,344

$

1

$

597

$

155,748

All of the Company’s marketable debt securities at September 30, 2019, have a contractual maturity of one year or less.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows:

As of September 30, 

As of December 31, 

2019

    

2018

(in thousands)

Cash and cash equivalents

$

82,640

$

46,859

Restricted cash included in deposits and other non-current assets

735

735

Total cash, cash equivalents, and restricted cash

$

83,375

$

47,594